Full course description
Description
This training provides an in-depth understanding of the phases of clinical trials, ethical considerations, and methodological frameworks such as randomisation and blinding. It discusses the importance of clinical endpoints, risk assessment, and the role of Ethics Committees in ensuring participant safety.
Target Audience
Healthcare professionals, Ethics Committee members, clinical researchers, and anyone involved in the planning, review, or execution of clinical trials.
Learning Outcomes
After completing this training, you will be able to:
- Differentiate between the phases of clinical trials and their objectives.
- Explain the role of ethical guidelines, such as the Declaration of Helsinki, in clinical research.
- Assess the importance of randomisation, blinding, and endpoint selection in trial design.
- Evaluate the responsibilities of Ethics Committees in protecting trial participants.